Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00281
|
|||||
| Drug Name |
Progesterone
|
|||||
| Synonyms |
LPCN-1107; Progesterone (oral, preterm labor); Progesterone (oral, preterm labor), Lipocine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Premature labour [ICD11: JB00] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H30O2
|
|||||
| Canonical SMILES |
CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
|
|||||
| InChI |
InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1
|
|||||
| InChIKey |
RJKFOVLPORLFTN-LEKSSAKUSA-N
|
|||||
| CAS Number |
CAS 57-83-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 314.5 | Topological Polar Surface Area | 34.1 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
3.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10318966
, 10321434
, 110315
, 11446518
, 11466505
, 11467625
, 11486289
, 12015027
, 14850243
, 14874443
, 17388760
, 17389514
, 17405453
, 24278618
, 24870355
, 24898476
, 24898649
, 24898857
, 24898978
, 24899064
, 25621439
, 26715972
, 26719639
, 26746572
, 26751485
, 26751486
, 26759395
, 29204503
, 29225009
, 3139517
, 3700
, 46386909
, 46391718
, 46392093
, 625872
, 6435812
, 6436726
, 6436727
, 75083
, 7847134
, 7890619
, 7980395
, 8026442
, 8144717
, 8153728
, 818903
, 834065
, 837053
, 841781
, 855688
|
|||||
| ChEBI ID |
CHEBI:17026
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | P-GP | Transporter Info | Km = 30 microM | Chinese hamster ovary AA8 cells-MDR1 | [4] | |
| P-GP | Transporter Info | Km = 53.6 microM | High five cells-MDR1 | [3] | ||
| References | ||||||
| 1 | Progesterone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem. 2003 Jun 6;278(23):20645-51. | |||||
| 3 | Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8. | |||||
| 4 | Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem. 1996 Feb 9;271(6):3163-71. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.